Revenue: As of FY2025 Q2, the actual value is USD 0.EPS: As of FY2025 Q2, the actual value is USD -0.1.EBIT: As of FY2025 Q2, the actual value is USD -98.91 K.<h3>Segment Revenue</h3><ul><li>Interest Income on Investments Held in Trust Account: $25,966 for the three months ended June 30, 2025, and $67,106 for the six months ended June 30, 2025.</li></ul><h3>Operational Metrics</h3><ul><li>Net Loss: $542,059 for the three months ended June 30, 2025, and $616,178 for the six months ended June 30, 2025.</li><li>Formation and Operating Costs: $72,946 for the three months ended June 30, 2025, and $148,774 for the six months ended June 30, 2025.</li><li>Change in Fair Value of Warrant Liability: - $495,079 for the three months ended June 30, 2025, and - $534,510 for the six months ended June 30, 2025.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: - $148,081 for the six months ended June 30, 2025.</li><li>Net Cash Provided by Financing Activities: $148,081 for the six months ended June 30, 2025.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to complete its initial business combination by October 14, 2025, and has extended the date by which it has to complete a business combination on a month-to-month basis until October 14, 2026.</li><li>Non-Core Business: The company has entered into a Business Combination Agreement with Leading Group Limited, a provider of insurance products in the People’s Republic of China, and plans to exchange its ordinary shares for Holdco Class A shares on a one-on-one basis at closing.</li><li>Priority: The company aims to maintain its listing on Nasdaq for the post-business combination combined company’s securities, which is a condition precedent to closing the Business Combination.</li></ul>

HEALTHCARE AI ACQUISITION CORP C/WTS (TO PUR COM) | 10-Q: FY2025 Q2 Revenue: USD 0